awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26798822-82AC282F-D47B-443D-85EB-D6AE933BDDDB
Q26798822-82AC282F-D47B-443D-85EB-D6AE933BDDDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798822-82AC282F-D47B-443D-85EB-D6AE933BDDDB
Tumour Angiogenesis and Angiogenic Inhibitors: A Review
P2860
Q26798822-82AC282F-D47B-443D-85EB-D6AE933BDDDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798822-82AC282F-D47B-443D-85EB-D6AE933BDDDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
84ebb44faee0ce132635f23bd81b2e77e61aef57
P2860
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling